Tower Research Capital LLC (Trc) Aadi Bioscience, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 797 shares of AADI stock, worth $1,362. This represents 0.0% of its overall portfolio holdings.
Number of Shares
797
Previous 4,098
80.55%
Holding current value
$1,362
Previous $7,000
85.71%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding AADI
# of Institutions
44Shares Held
29.4MCall Options Held
0Put Options Held
0-
Qvt Financial LP New York, NY4.62MShares$7.89 Million0.65% of portfolio
-
Orbimed Advisors LLC San Diego, CA4.17MShares$7.12 Million0.24% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.7MShares$6.33 Million0.19% of portfolio
-
Acuta Capital Partners, LLC Belmont, CA3.41MShares$5.83 Million10.98% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.85MShares$4.87 Million0.07% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $35.9M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...